Authors:
SEGMAN RH
SHAPIRA Y
KANYAS K
HIRSCHMANN S
HERESCOLEVY U
KARNI O
TURETSKY N
SHAPIRA B
SHELEVOY A
MODAI I
LERER B
Citation: Rh. Segman et al., ANGIOTENSIN-CONVERTING ENZYME POLYMORPHISM IN SCHIZOPHRENIA AND MAJORAFFECTIVE-DISORDER - POPULATION AND FAMILY-BASED ASSOCIATION STUDIES, American journal of medical genetics, 81(6), 1998, pp. 522-523
Authors:
SHAPIRA B
TUBI N
DREXLER H
LIDSKY D
CALEV A
LERER B
Citation: B. Shapira et al., COST AND BENEFIT IN THE CHOICE OF ECT SCHEDULE - TWICE VERSUS 3 TIMESWEEKLY ECT, British Journal of Psychiatry, 172, 1998, pp. 44-48
Authors:
KOHN Y
EBSTEIN RP
HERESCOLEVY U
SHAPIRA B
NEMANOV L
GRITSENKO I
AVNON M
LERER B
Citation: Y. Kohn et al., DOPAMINE D4 RECEPTOR GENE POLYMORPHISMS - RELATION TO ETHNICITY, NO ASSOCIATION WITH SCHIZOPHRENIA AND RESPONSE TO CLOZAPINE IN ISRAELI SUBJECTS, European neuropsychopharmacology, 7(1), 1997, pp. 39-43
Authors:
LERER B
SHAPIRA B
TUBI N
CALEV A
LIDSKY D
Citation: B. Lerer et al., A NEW CONTROLLED TRIAL OF TWICE VERSUS 3 TIMES WEEKLY ECT - CLINICAL IMPLICATIONS, Convulsive therapy, 13(1), 1997, pp. 51-51
Citation: B. Shapira et al., HYPERTEXT BROWSING - A NEW MODEL FOR INFORMATION FILTERING BASED ON USER PROFILES AND DATA CLUSTERING, Online & CD ROM review, 20(1), 1996, pp. 3-10
Authors:
BONNE O
KRAUSZ Y
GORFINE M
KARGER H
GELFIN Y
SHAPIRA B
CHISIN R
LERER G
Citation: O. Bonne et al., CEREBRAL HYPOPERFUSION IN MEDICATION RESISTANT, DEPRESSED-PATIENTS ASSESSED BY TC99M HMPAO SPECT, Journal of affective disorders, 41(3), 1996, pp. 163-171
Authors:
BONNE O
KRAUSZ Y
SHAPIRA B
BOCHER M
KARGER H
GORFINE M
CHISIN R
LERER B
Citation: O. Bonne et al., INCREASED CEREBRAL BLOOD-FLOW IN DEPRESSED-PATIENTS RESPONDING TO ELECTROCONVULSIVE-THERAPY, The Journal of nuclear medicine, 37(7), 1996, pp. 1075-1080
Citation: B. Shapira et B. Lerer, CHOOSING A DOSING STRATEGY FOR ELECTRICAL-STIMULATION IN ECT - REPLY, The Journal of clinical psychiatry, 57(10), 1996, pp. 487-488
Citation: B. Shapira et al., ELECTROCONVULSIVE-THERAPY AND RESISTANT DEPRESSION - CLINICAL IMPLICATIONS OF SEIZURE THRESHOLD, The Journal of clinical psychiatry, 57(1), 1996, pp. 32-38
Citation: Rh. Segman et al., ONSET AND TIME-COURSE OF ANTIDEPRESSANT ACTION - PSYCHOPHARMACOLOGICAL IMPLICATIONS OF A CONTROLLED TRIAL OF ELECTROCONVULSIVE-THERAPY, Psychopharmacology, 119(4), 1995, pp. 440-448
Citation: B. Shapira et al., A PROSPECTIVE-STUDY OF LITHIUM CONTINUATION THERAPY IN DEPRESSED-PATIENTS WHO HAVE RESPONDED TO ELECTROCONVULSIVE-THERAPY, Convulsive therapy, 11(2), 1995, pp. 80-85
Authors:
LERER B
SHAPIRA B
CALEV A
TUBI N
DREXLER H
KINDLER S
LIDSKY D
SCHWARTZ JE
Citation: B. Lerer et al., ANTIDEPRESSANT AND COGNITIVE EFFECTS OF TWICE-WEEKLY VERSUS 3-TIMES-WEEKLY ECT, The American journal of psychiatry, 152(4), 1995, pp. 564-570
Citation: B. Shapira et al., SEROTONERGIC MECHANISMS IN DEPRESSION - CLINICAL INSIGHTS AND BIOLOGICAL CORRELATES, Israel journal of medical sciences, 30(2), 1994, pp. 162-167
Authors:
TUBI N
CALEV A
NIGAL D
SHAPIRA B
FINK M
PASS HL
JANDORF L
LERER B
Citation: N. Tubi et al., SUBJECTIVE SYMPTOMS IN DEPRESSION AND DURING THE COURSE OF ELECTROCONVULSIVE-THERAPY, Neuropsychiatry, neuropsychology, and behavioral neurology, 6(3), 1993, pp. 187-192
Citation: B. Shapira et al., PROLACTIN RESPONSE TO FENFLURAMINE AND PLACEBO CHALLENGE FOLLOWING MAINTENANCE PHARMACOTHERAPY WITHDRAWAL IN REMITTED DEPRESSED-PATIENTS, Biological psychiatry, 33(7), 1993, pp. 531-535
Citation: B. Shapira et B. Lerer, HORMONE RESPONSE TO FENFLURAMINE CHALLENGE AND THE OUTCOME OF ANTIDEPRESSANT TREATMENT, Biological psychiatry, 33(6A), 1993, pp. 74-74
Citation: B. Shapira et al., OPTIMAL USE OF ELECTROCONVULSIVE-THERAPY - CHOOSING A TREATMENT SCHEDULE, The Psychiatric clinics of North America, 14(4), 1991, pp. 935-946